Dr Marius Wernig, Professor at Stanford University and Co-director of the Institute of Stem Cell Biology and Regenerative Medicine, has paved the way for the application of induced pluripotent stem cells (iPSCs) to cure Epidermolysis Bullosa (EB). StemFit® culture medium, manufactured by Ajinomoto and available globally from AMSBIO has been a staple in Dr Wernig’s lab from early on in his research, providing a reliable medium to maintain normal karyotype and pluripotency of the iPSCs.
Cell surface levels of Heparan Sulfate preserved using CELLBANKER 2September 27, 2022
How to be GMP Ready: A GuideAugust 31, 2022
Summary of key findings
AMSBIO's Stem Cell Synergy Solutions
StemFit® is a range of xeno-free, chemically defined media proven to effectively maintain iPSCs and embryonic stem cells (ESCs) under feeder-free conditions during the reprogramming, expansion and differentiation phases of stem cell culture and growth medium. Available in research grade and GMP formulations, StemFit® combines market-leading colony forming efficiency with lower than standard media volume-consumption to offer the most cost-effective colony expansion compared to leading competitors.